Showing results (1321-1330 of 3,353) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|August 1, 2018
Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging IssuesPatricia M DanzonPharmacoeconomics|July 22, 2018
Model Structuring for Economic Evaluations of New Health TechnologiesHossein Haji Ali Afzali, Laura Bojke, Jonathan KarnonPharmacoeconomics|May 25, 2017
Using Discrete Choice Experiments to Inform the Benefit-Risk Assessment of Medicines: Are We Ready Yet?Caroline M Vass, Katherine PaynePharmacoeconomics|March 13, 2010
Cost effectiveness of etoricoxib versus celecoxib and non-selective NSAIDS in the treatment of ankylosing spondylitisJeroen P Jansen, Sabine Gaugris, Ernest H Choy, et al.Pharmacoeconomics|May 26, 2018
Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UKVanessa Buchanan, Will Sullivan, Chris Graham, et al.Pharmacoeconomics|May 16, 2018
Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility AnalysisJesse Elliott, Bláthnaid McCoy, Tammy Clifford, et al.Pharmacoeconomics|July 5, 2018
Modeling Approaches in Cost-Effectiveness Analysis of Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: An Updated Systematic Review and Recommendations for Future Economic EvaluationsLuis Hernandez, Malinda O'Donnell, Maarten PostmaPharmacoeconomics|July 8, 2018
Economic Evaluation for the UK of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic CancerMahdi Gharaibeh, Ali McBride, David S Alberts, et al.Pharmacoeconomics|January 21, 2010
Can't get no satisfaction? Will pay for performance help?: toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical productsAdrian Towse, Louis P GarrisonPageof 336